Non-melanoma Skin Cancer Clinical Trials

9 recruitingLast updated: June 17, 2026

There are 9 actively recruiting non-melanoma skin cancer clinical trials across 5 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3. Top locations include Beijing, Beijing Municipality, China, Bern, Switzerland, Calgary, Alberta, Canada. Updated daily from ClinicalTrials.gov.


Non-melanoma Skin Cancer Trials at a Glance

9 actively recruiting trials for non-melanoma skin cancer are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Beijing, Bern, and Calgary. Lead sponsors running non-melanoma skin cancer studies include Wright State University, Essen Biotech, and DermBiont, Inc..

Browse non-melanoma skin cancer trials by phase

Treatments under study

About Non-melanoma Skin Cancer Clinical Trials

Looking for clinical trials for Non-melanoma Skin Cancer? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Non-melanoma Skin Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Non-melanoma Skin Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Liver CancerMelanomaMerkel Cell Carcinoma+9 more
Istituto Oncologico Veneto IRCCS24 enrolled1 locationNCT06753136
Recruiting
Phase 1Phase 2

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Colorectal, CancerEsophageal CancerOvarian Cancer+12 more
Essen Biotech83 enrolled1 locationNCT07410676
Recruiting

Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically

Non-melanoma Skin Cancer (NMSC)Benign Skin Growth
Dartmouth-Hitchcock Medical Center125 enrolled1 locationNCT07201376
Recruiting
Phase 2

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Chronic Lymphocytic LeukemiaNon-melanoma Skin Cancer (NMSC)
University of Utah86 enrolled1 locationNCT04844528
Recruiting
Not Applicable

Skin Cancer and Hyperthermia and Radiotherapy

Squamous Cell Carcinoma (Skin)Basal Cell CarcinomaNon-melanoma Skin Cancer
Kantonsspital Winterthur KSW100 enrolled4 locationsNCT06384053
Recruiting
Not Applicable

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

Non-melanoma Skin CancerAgingActinic Keratoses
Wright State University72 enrolled1 locationNCT03906253
Recruiting
Phase 3

Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

Carcinoma, Squamous CellNon-melanoma Skin CancerCarcinoma, Basal Cell+1 more
Women's College Hospital396 enrolled7 locationsNCT05955924
Recruiting
Not Applicable

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

Non-melanoma Skin CancerAgingActinic Keratoses
Wright State University80 enrolled1 locationNCT06428721
Recruiting
Phase 2

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers

Non-Melanoma Skin Cancers
DermBiont, Inc.50 enrolled1 locationNCT06409195